Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Nevakar Inc. logo — Repositioning Drugs for a Better Outcome®

Nevakar Inc.

Repositioning Drugs for a Better Outcome®

Founded 2015 United States Bridgewater, United States 35 employees Private Equity Total: $135.00M Biopharma, Biotechnology +1

General Information

Company Name Nevakar Inc.
Founded Year 2015
Location United States Bridgewater, United States
Employees 35
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage Private Equity
Social

BounceWatch is an independent company data service, not affiliated with Nevakar Inc.. To contact Nevakar Inc., visit nevakar.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Nevakar Inc. compare?

A PDF of Nevakar Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Nevakar Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Nevakar Inc.

Nevakar Inc. is a specialty injectable pharmaceutical company, with the slogan "Repositioning Drugs for a Better Outcome®." Established in 2015 and headquartered in the United States, the company is focused on developing innovative products in injectable and ophthalmic space. Nevakar's goal is to develop enhanced products that address unmet clinical and/or commercial needs of currently [FDA] approved molecules, through intensive R&D and clinical efforts. The company recently received a significant $50.00M Private Equity Round investment on 18 June 2019 from Novaquest Capital Management. With a focus on Biopharma, Biotechnology, and Pharmaceutical industries, Nevakar is well-positioned to drive innovation and address unmet needs in the pharmaceutical space.

Business keywords: specialty pharmaceuticals, injectable medications, ophthalmic products, innovative drug development, FDA-approved molecules, R&D, clinical research, unmet medical needs, pharmaceutical company, NJ Center of Excellence, management team, drug repositioning, enhanced products, commercial needs, state-of-the-art infrastructure

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round $50.00M 1
Novaquest Capital Management
Novaquest Capital Management
18 Jun 2019
Debt Financing $30.00M 2
Armentum Partners
Armentum Partners, Oxford Finance LLC
30 Nov 2018
Private Equity Round $55.00M -
28 Jul 2016

Nevakar Inc. Alternatives & Competitors

View All Alternatives
Nevakar Inc. vs
CytoAgents, Inc
CytoAgents, Inc United States

Calming the Cytokine Storm, Rebalancing the Immune System. Accessible treatment for multiple areas...

Series A
10 employees
Biotechnology, Health Care
Nevakar Inc. vs
IXALTIS SA
IXALTIS SA France

DEVELOPING INNOVATIVE TREATMENTS FOR GENITOURINARY TRACT DISORDERS

Venture round
2 employees
Biopharma, Biotechnology
Nevakar Inc. vs
Xanodyne Pharmaceuticals
Xanodyne Pharmaceuticals United States

Xanodyne Pharmaceuticals, Inc., founded in 2001, is an integrated specialty pharmaceutical company w...

Venture round
50 employees
Biotechnology, Health Care
View all alternatives

FAQ About Nevakar Inc.

Repositioning Drugs for a Better Outcome®
Nevakar Inc. was founded in 2015.
Nevakar Inc. is headquartered in Bridgewater, United States.
Nevakar Inc. operates in Biopharma, Biotechnology and Pharmaceutical. Its work centres on specialty pharmaceuticals, injectable medications, ophthalmic products and innovative drug development.
Nevakar Inc. has approximately 35 employees.
Nevakar Inc. has completed 3 funding rounds, raising a total of $135.00M. The latest funding stage is Private Equity.
Top alternatives and competitors to Nevakar Inc. include CytoAgents, Inc, IXALTIS SA, Xanodyne Pharmaceuticals, Talphera, Inc., Quoin Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nevakar Inc. and CytoAgents, Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Nevakar Inc., https://bouncewatch.com/company/nevakar-inc, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout